Vaxart Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.66. In total, the insiders bought 23.07M and sold 408.43K VXRT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
94.66
Buy 23.07M shares
Sell 408.43K shares
81% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Mar 24, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.66.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 22, 2026
Buy
Common Stock
P-Purchase
Watson W. Mark
Director
Director 10 000
Value: $7K
May 19, 2026
Sell
Common Stock
F-InKind
Grasman Jeroen Nicolaas
Chief Financial Officer
C-Suite Officer 31 395
Value: $19.2K
Apr 23, 2026
Buy
Common Stock
J-Other
Breitmeyer James B
Director 0
Value: $0
Apr 23, 2026
Buy
Stock Option (right to buy)
A-Award
Breitmeyer James B
Director
Director 157 400
Value: $116.5K
Apr 23, 2026
Buy
Common Stock
A-Award
Breitmeyer James B
Director
Director 78 800
Value: $58.3K
Mar 28, 2026
Sell
Common Stock
F-InKind
Tucker Sean
SVP, Chief Scientific Officer
Officer 3 924
Value: $3K
Mar 28, 2026
Sell
Common Stock
F-InKind
Cummings James F.
Chief Medical Officer
Officer 3 292
Value: $2K
Mar 24, 2026
Sell
Common Stock
F-InKind
Cummings James F.
Chief Medical Officer
Officer 30 551
Value: $21.2K
Mar 24, 2026
Sell
Common Stock
F-InKind
Berg Edward B
SVP, General Counsel
Officer 36 418
Value: $25.3K
Mar 24, 2026
Sell
Common Stock
F-InKind
Lo Steven
President, Chief Exec Officer
CEO / President 126 028
Value: $87.5K
Mar 24, 2026
Sell
Common Stock
F-InKind
Tucker Sean
SVP, Chief Scientific Officer
Officer 36 418
Value: $25.3K
Mar 18, 2026
Sell
Common Stock
F-InKind
Tucker Sean
SVP, Chief Scientific Officer
Officer 8 072
Value: $5K
Mar 18, 2026
Sell
Common Stock
F-InKind
Lo Steven
President, Chief Exec Officer
CEO / President 22 425
Value: $14.2K
Mar 18, 2026
Sell
Common Stock
F-InKind
Cummings James F.
Chief Medical Officer
Officer 6 772
Value: $4K
Mar 18, 2026
Sell
Common Stock
F-InKind
Berg Edward B
SVP, General Counsel
Officer 8 072
Value: $5K
Mar 16, 2026
Buy
Common Stock
A-Award
Berg Edward B
SVP, General Counsel
Officer 115 000
Value: $78.1K
Mar 16, 2026
Buy
Stock Option (right to buy)
A-Award
Cummings James F.
Chief Medical Officer
Officer 455 000
Value: $309.2K
Mar 16, 2026
Buy
Common Stock
A-Award
Cummings James F.
Chief Medical Officer
Officer 227 000
Value: $154.2K
Mar 16, 2026
Buy
Common Stock
A-Award
Tucker Sean
SVP, Chief Scientific Officer
Officer 200 000
Value: $135.9K
Mar 16, 2026
Buy
Stock Option (right to buy)
A-Award
Tucker Sean
SVP, Chief Scientific Officer
Officer 410 000
Value: $278.6K
Mar 16, 2026
Buy
Common Stock
A-Award
Grasman Jeroen Nicolaas
Chief Financial Officer
C-Suite Officer 227 000
Value: $154.2K
Mar 16, 2026
Buy
Stock Option (right to buy)
A-Award
Grasman Jeroen Nicolaas
Chief Financial Officer
C-Suite Officer 455 000
Value: $309.2K
Mar 16, 2026
Buy
Stock Option (right to buy)
A-Award
Berg Edward B
SVP, General Counsel
Officer 225 000
Value: $152.9K
Mar 16, 2026
Buy
Common Stock
A-Award
Lo Steven
President, Chief Exec Officer
CEO / President 846 500
Value: $575.2K
Mar 16, 2026
Buy
Stock Option (right to buy)
A-Award
Lo Steven
President, Chief Exec Officer
CEO / President 1 543 000
Value: $1.05M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VAXART
Vaxart
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE